Diamonds and Dogs

12/30/14

NeuroDerm Ltd. (NDRM)

NeuroDerm more than hit the daily double today, up 162.46% to $16.22. The pharmaceutical company saw its shares explode after encouraging news from their Parkinson's drug. NeuroDerm announced continuous, subcutaneous dosage of two of its proprietary liquid levodopa/carbidopa (LD/CD) product candidates, ND0612H and ND0612L, resulted in clinically significant plasma levadopa levels. The data indicates that the high dose version, ND0612H, meant for patients with severe Parkinson's disease, could be an effective therapy alternative to current treatments that require surgery. Shares of the company climbed over $10 per share today and hit a new 52-week high of $16.73 intraday.

Civeo Corporation (CVEO)

Civeo Corporation is getting hit hard today, down 52.00% to $3.97. The Canadian oil sands company watched its shares fall after oil prices continued their decline, which is affecting Civeo's outlook. The oil and gas field services company now expects revenue of $160 million to $175 million, below the $196.5 million analysts were expecting. Furthermore, Civeo also sees 2015 revenue of $540 million to $600 million vs. the $725 million that analysts forecast. Due to the lower expectations; the company suspended its dividend, and analysts from Susquehanna lowered their price target from $10 to $6. Shares of Civeo fell over $4.30 today to a new 52-week low of $3.88.